QuickView for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=C1188DFB6C25D0C9A6AAC30CD302840A;jsessionid=5AD4C6133ACA818024C50947731D98BB;jsessionid=10FFC983A15314F120B78CAEE68677D1;jsessionid=F716B8971AEFA5AC4CC4BE33C1CD9688;jsessionid=3E7AF12C0BB3FF872C3F4E4211F34A33 (gene)

1. Thymic stroma and TFII-I: towards new targeted therapies.
2. Proteomic analysis of SRF associated transcription complexes identified TFII-I as modulator of SRF f…
3. Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C.
4. The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and dis…
5. Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII.

There were no clinical trials for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=C1188DFB6C25D0C9A6AAC30CD302840A;jsessionid=5AD4C6133ACA818024C50947731D98BB;jsessionid=10FFC983A15314F120B78CAEE68677D1;jsessionid=F716B8971AEFA5AC4CC4BE33C1CD9688;jsessionid=3E7AF12C0BB3FF872C3F4E4211F34A33